#BioGenex

[bhavanameti]

Slide Stainers Market Projected to Reach $5.53 Billion by 2030

Meticulous Research®—a leading global market research company, published a research report titled, ‘Slide Stainers Market by Product (Reagent [Stains, Mounting, Tissue Fixation, Processing] Equipment), Technique (H&E, ISH, IHC, Hematology, Cytology), Application (Diagnosis, Research), End User (Hospital, Pharmaceutical, Academic) - Global Forecast to 2030.’

According to the latest publication from Meticulous Research®, the slide stainers market is projected to reach $5.53 billion by 2030, growing at a CAGR of 7.9% during the forecast period. This market growth is driven by factors such as the increasing geriatric population, the rising prevalence of chronic diseases, advancements in slide stainer technology, the growing need for personalized treatments, higher healthcare expenditures, the demand for automation in diagnostics and clinical research, and the increasing focus on cancer drug research. Emerging economies and the rising demand for automated slide staining and diagnostic systems also present significant growth opportunities. However, the high cost of slide stainer systems and concerns about automated slide stainers, along with a lack of skilled professionals, pose challenges to market growth.

Key Players

The key players in the slide stainers market include Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Abcam plc. (U.K.), Siemens Healthineers (Germany), General Data Company, Inc. (U.S.), Biocare Medical, LLC. (U.S.), BioGenex (U.S.), PHC Holdings Corporation (Japan), and Hardy Diagnostics (U.S.).

Market Segmentation

The slide stainers market is segmented by:

Product:

Reagents and Kits (including Grossing/Tissue Marking Dyes, Tissue Fixation Reagents, Tissue Processing Reagents, Mounting/Embedding Reagents, Stains [Hematoxylin and Eosin (H&E) Stains, Cytology Stains, Special Stains, Stain Controls, and Other Reagents & Kits])

Equipment (Automated Slide Stainers and Manual Slide Stainers)

Accessories and Consumables

Technique:

Hematoxylin and Eosin (H&E)

In-situ Hybridization (ISH)

Immunohistochemistry (IHC)

Hematology

Cytology

Microbiology

Application:

Disease Diagnosis (Infectious Diseases, Cancer, and Other Diseases)

Medical Research

End User:

Hospitals & Diagnostic Centers

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Contract Research Organizations (CROs)

Geography:

North America (U.S. and Canada)

Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe)

Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific)

Latin America

Middle East & Africa

In 2023, North America is expected to hold the largest share of the slide stainers market, followed by Europe and Asia-Pacific. The U.S. is projected to be the largest market in North America, driven by its well-developed healthcare infrastructure and the presence of major market players.

Segment Highlights

Product: The reagents & kits segment is expected to dominate the market in 2023 due to the growth in clinical research and development activities and the increasing adoption of laboratory automation solutions.

Technique: The hematoxylin and eosin (H&E) segment is anticipated to hold the largest market share in 2023, favored by its extensive use in examining tissue and cellular structures in research and diagnosis of various diseases.

End User: Hospitals & diagnostic centers are expected to be the largest end-user segment in 2023, driven by the growing patient influx and the need for automated solutions to improve diagnostic efficiency and accuracy.

Geographic Analysis

The report provides an in-depth analysis of major regions including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is expected to lead the market in 2023, supported by advanced healthcare infrastructure and significant investments in research and development.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5643

Key Questions Addressed in the Report:

Which market segments are expected to experience the highest growth?

What was the historical market size globally?

What are the market forecasts from 2023 to 2030?

What are the key drivers, restraints, opportunities, and challenges?

Who are the major players in the market?

What is the competitive landscape like?

What recent developments have occurred in the market?

What strategies are the leading players adopting?

Which regions/countries are exhibiting high growth?

This comprehensive report provides detailed insights into the slide stainers market, helping stakeholders make informed decisions and capitalize on emerging opportunities.

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research 

[bhavesh2022]

Europe Anatomic Pathology Market Trends, and Forecasts by 2028

The market research study titled “Europe Anatomic Pathology Market Share, Trends, and Outlook | 2028,” guides organizations on market economics by identifying current Europe Anatomic Pathology market size, total market share, and revenue potential. This further includes projections on future market size and share in the estimated period. The company needs to comprehend its clientele and the demand it creates to focus on a smaller selection of items. Through this chapter, market size assists businesses in estimating demand in specific marketplaces and comprehending projected patterns for the future.

The Europe Anatomic Pathology market report also provides in-depth insights into major industry players and their strategies because we understand how important it is to remain ahead of the curve. Companies may utilize the objective insights provided by this market research to identify their strengths and limitations. Companies that can capitalize on the fresh perspective gained from competition analysis are more likely to have an edge in moving forward.

With this comprehensive research roadmap, entrepreneurs and stakeholders can make informed decisions and venture into a successful business. This research further reveals strategies to help companies grow in the Europe Anatomic Pathology market.

Market Analysis and Forecast

This chapter evaluates several factors that impact on business. The economics of scale described based on market size, growth rate, and CAGR are coupled with future projections of the Europe Anatomic Pathology market. This chapter is further essential to analyze drivers of demand and restraints ahead of market participants. Understanding Europe Anatomic Pathology market trends helps companies to manage their products and position themselves in the market gap.

This section offers business environment analysis based on different models. Streamlining revenues and success is crucial for businesses to remain competitive in the Europe Anatomic Pathology market. Companies can revise their unique selling points and map the economic, environmental, and regulatory aspects.

Report Attributes

Details

Segmental Coverage

Product and Service

Instruments

Consumables

and Services

Application

Disease Diagnosis

Drug Discovery and Development

and Others

End User

Hospitals

Research Laboratories

Diagnostic Laboratories

and Others

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

F. HOFFMANN-LA ROCHE LTD.

Danaher

Hologic, Inc.

Agilent Technologies, Inc.

BioGenex

Diapath S.p.A.

Bio SB

MERCK KGaA

BD

PHC Holdings Corporation

Other key companies 

Our Unique Research Methods at Business Market Insights

We offer syndicated market research solutions and consultation services that provide complete coverage of global markets. This report includes a snapshot of global and regional insights. We pay attention to business growth and partner preferences, that why we offer customization on all our reports to meet individual scope and regional requirements.

Our team of researchers utilizes exhaustive primary research and secondary methods to gather precise and reliable information. Our analysts cross-verify facts to ensure validity. We are committed to offering actionable insights based on our vast research databases.

Strategic Recommendations

Strategic planning is crucial for business success. This section offers strategic recommendations needed for businesses and investors. Forward forward-focused vision of a business is what makes it through thick and thin. Knowing business environment factors helps companies in making strategic moves at the right time in the right direction.

Summary:

Europe Anatomic Pathology Market Forecast and Growth by Revenue | 2028

Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities

Market Segmentation – A detailed analysis by product, types, end-user, applications, segments, and geography

Competitive Landscape – Top key players and other prominent vendors

Author’s Bio: Bhavesh Shinde Senior Market Research Expert at Business Market Insights

[researchupdates]

Global Anatomic Pathology Market Growth Statistics to Make Multi-Billion Dollar Market during 2021-2028

Overview of the Global Anatomic Pathology Market:

A realistic Anatomic Pathology Market research report contains most recent Market information with which companies can have in depth analysis of Healthcare industry and future trends. It becomes easy to figure out brand awareness and insight about the brand and product among potential customers. This industry report helps divulge uncertainties that may arise due to changes in business activities or introduction of a new product in the Market. The Market report is a specific study of the Healthcare industry which explains what the Market definition, classifications, applications, engagements, and global industry trends are. Global Anatomic Pathology Market report acts as a significant component of business strategy.

By keeping into the focus customer requirements, Anatomic Pathology Market document has been crafted by chewing over bountiful of Market parameters. This industry analysis report explains Market segmentation in the most-detailed pattern as well as conducts thorough analysis of patents and major Market players to present a competitive landscape. In today’s competitive Market place, businesses are always in struggle to look for better solutions in terms of product trends, future products, Marketing strategy, future events, actions or behaviors. With the comprehensive Anatomic Pathology report, it has been assured that an absolute knowledge and insights about the new regulatory environment which suits to their organization are provided.

Get a Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-anatomic-pathology-market .

The Global Anatomic Pathology Market is expected to rise from its initial estimated value of USD 18.66 Billion in 2018 to an estimated value of USD 30.53 Billion by 2026, registering a CAGR of 6.35% in the forecast period of 2019-2026.

According to market research study, Anatomic pathology is a medical speciality that is required in the diagnosis of disease based on the microscopic, macroscopic, biochemical, immunologic and molecular examination of organs and tissues. In the last few years, surgical pathology has evolved extremely, from an ancient examination of whole bodies (autopsy) to modern techniques needed for the diagnosis and prognosis of cancer to guide treatment decision-making in oncology.

The major competitors currently working in the Global Anatomic Pathology Market are F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc.(U.S.), Koninklijke Philips N.V.( Netherlands), Leica Microsystems(Germany), Digipath, Inc.(U.S.), Laboratory Corporation of America Holdings (U.S.), Danaher(U.S.)., Angsana Molecular & Diagnostics Laboratory Pte Ltd. (Singapore), Quest Diagnostics Incorporated.(U.S.), Agilent Technologies, Inc (U.S.), Sakura Tech (Singapore), BioGenex, Bio SB (U.S.), NeoGenomics Laboratories, Inc.(U.S.), Nikon Corporation(Japan), PerkinElmer, Inc.(U.S.), Definiens (Germany), Boston Scientific Corporation(U.S.), Advanced Cell Diagnostics, Inc.(U.S.), Tecan Trading AG(Switzerland), RareCyte, Inc.(U.S.), Oxford Cancer Biomarkers Ltd. (U.K.), Enzo Biochem Inc. (U.S.), and Epic Sciences (U.S.) among others.

The most significant key factors driving the growth of the Global Anatomic Pathology Market are increasing incidence of cancer is in the world is working as a driver for the industry, emerging technology in medical devices is a driver for the industry.

Access Complete Report Here: https://www.databridgemarketresearch.com/reports/global-anatomic-pathology-market .

[healthcaremarketfmi]

Anatomic Pathology Market Detailed Survey On Key Trends, Leading Players & Revolutionary Opportunities 2030

The global anatomic pathology market forecast is set to reach US$ 61.1 Mn in revenues by 2030, according to a new market study by ESOMAR-certified market research firm, Future Market Insights (FMI).

The anatomic pathology market is subject to integrating medical informatics standards to meet specific healthcare requirements by curtailing costs and improvising on efficiency.

Pathology laboratories are on the verge of refurbishment as new-fangled disease diagnostic models are making a beeline therein.

As of now, lymphoma, breast cancer, colorectal cancer, prostate cancer, cervical cancer, and lung cancer are a part of anatomic pathology.

Get Sample Report + Related Graphs & Charts @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12370

Key Takeaways

The instruments are subject to technological advancements, which would minimize errors. This factor is expected to drive the anatomic pathology market between 2022 and 2030

Consumables are expected to hold the largest market share due to low cost, high availability, and good purchase rate of probes and reagents

Academic research is bound to pick up pace in the forecast period owing to growing implementation of anatomic pathology in biomarker profiling and tumor examination

Preference to personalized therapies is prompting putative biomarkers being discovered. This factor is expected to be one of the key growth drivers

Key Participant Insights

The key market players are focusing on technological upgradations and expansion strategies to keep themselves fiercely competitive.

For instance –

In Jul 2020, Bio SB tabled its Fast Mohs PolyDetector Plus Detection System, which comes across as a super sensitive nonbiotin monovalent Fab micropolymer immunohistochemistry system to detect IVD antibodies for squamous cell carcinoma, basal cell carcinoma, and melanoma.

In Jan 2019, Quest Diagnostics announced completion of acquisition of the US laboratory services business that belonged to Oxford Immunotec (the T-Spot and Accutix tick-borne disease testing services, since then, are part of Quest’s infectious disease testing services.

In 2018, Leica Microsystems entered into a collaboration with Thermo Fisher to develop an integrated cryotomography workflow with regards to research.

Expand operations in the future – To get requisite details, ask for a custom report@ https://www.futuremarketinsights.com/customization-available/rep-gb-12370

The other players in the veterinary imaging market include

Laboratory Corporation of America Holdings

Sakura Finetek USA, Inc.

F.Hoffmann-La Roche AG

Cardinal Health, Inc.

BioGenex

NeoGenomics

Agilent Technologies

The US continues to be one of the leading markets for anatomic pathology market globally. Strong presence of some of the leading players, combined with relatively easier funding for R&D will drive the US anatomic pathology market during the assessment period.

The Europe anatomic pathology market is also likely to grow at a brisk pace during the assessment period. The growth will remain concentrated in Western Europe, as has been the case traditionally.

Asia Pacific represents a high growth market for anatomic pathology stakeholders. Many countries in the region are renewing their focus on healthcare, as the current Covid-19 crisis has reinforced the necessity of a robust healthcare system.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global anatomic pathology market is segmented in detail to cover every aspect and present a complete market intelligence approach to the reader.

The study provides compelling insights on anatomic pathology market on the basis of product & services type (Instruments (Microtomes & Cryostat, Tissue processors, Automatic Stainers, and Other products), consumables (Reagents & Antibodies, Probes & Kits, and Others), application (Disease Diagnosis, Drug Discovery and Development, and Others), and services (histopathology, cytopathology)) across seven geographies.

[diigo123456]

IHC and IHS Slide Staining Systems Market is expected to offer significant growth at a CAGR of 6.5% during the forecast period 2023-2030 | Biocare Medical, BioGenex Laboratories, Celerus Diagnostics

The market for IHC and IHS (Immunohistochemistry and In Situ Hybridization) slide staining systems is expected to grow because of improvements in healthcare and the introduction of karyotyping and other tools in disease diagnosis. With these devices, automated staining can be done quickly, more efficiently, and with higher quality. This makes each test more productive. The global market for IHC and IHS slide staining systems is divided by type, application, and region. The market is split into four different types: systems, accessories, reagents, and consumables. By use, the immunohistochemistry and in situ hybridization slide staining system market is split into drug manufacturing, pathology research, and disease detection.Estimates and forecasts of the IHC and IHS Slide Staining Systems market size are given in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the years 2017 through 2030, with 2022 as the base year. 

Click Here For A Free Sample PDF Copy Of The IHC and IHS Slide Staining Systems Market Latest Research Before Purchase:

[pranalipawarshinde]

Cancer Diagnostics Market Technological Advances Detailed Analysis Report 2027

Cancer Diagnostics Market: Overview

 According to Transparency Market Research’s latest report on the global Cancer diagnostics Market for the historical period 2017–2018 and forecast period 2019–2027, Increasing trend for preventive diagnosis due to escalating prevalence continues, early diagnosis enables better clinical and economical outcomes for patients are projected to drive the global cancer diagnostics market during the forecast period.

According to the report, the global cancer diagnostics market was valued at US$ 146.2 Bn in 2018 and is anticipated to expand at a CAGR of 8.8% from 2019 to 2027.

Increasing trend for preventive diagnosis due to escalating prevalence continues and early diagnosis enables better clinical and economical outcomes for patients: Key Drivers

·         Cancer has a major impact on society across the world. It is one of the leading causes of death across the globe and is more prevalent in developed and emerging markets. According to American Cancer Society data, over 1.7 million new cancer cases are expected to be diagnosed in 2019 in the U.S. According to information published in the European Journal of Cancer, an estimated 3.9 million new cases of cancer and 1.9 million deaths due to the disease were reported in Europe in 2018.

·         The alarming rate of escalating cancer prevalence compels the healthcare providers to rethink of goals of treating cancer and also focus on prevention. This would require cancer diagnostics that are not only specific and sensitive, but also capable of detecting cancer in early stages. As the prevalence of different types of cancer grows globally, it is expected to drive the global cancer diagnostics market.

·         The high cost of treatment for any kind of cancer is a key driver for increasing market for diagnostic tests and procedures. Cancer is a chronic disease and usually incurs expensive treatment along with debilitating pain, disability and in some cases death. An early detection by use of most modern diagnostics enables quick medical decision making and consequent treatment. This ensures that the cancer does not prevail until it becomes very difficult to treat. Therefore, cancer diagnostics have significant role in reduction of treatment costs, lowering of hospitalization stay, and prevention of unavoidable interventions. Early diagnosis does not necessarily mean cost saving in the treatment of disease. It allows early treatment which results into improved quality of life and ‘quality adjusted life years’ (QALY) gained. The life years gained suffices the justification of even costlier cancer diagnostics and thus provides even better outlook for the Cancer Diagnostics Market

Request A Sample@

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3637

Novel Diagnostic Biomarkers Continue To Create New Revenue Stream Boost Market Growth

 ·         The increased knowledge about specific cancer biomarkers is providing great market opportunity to treat cancer patients through improvement in the detection. The technological advancements in the field of biotechnology have enabled the identification of potential cancer biomarkers and some of these biomarkers have been commercialized.

·         In February 2020, Biocare Medical launched of seven novel IVD immunohistochemistry antibody markers for clinical diagnostics and research applications.

·         In May 2020, BioGenex introduced three new primary immunohistochemistry (IHC) antibodies for cancer diagnosis. The new launch includes: CD8A, CD56, CD163

·        In 2014, Guardant Health introduced GUARDANT360 blood test that sequences patient’s cancer in real-time through genetic profiling of trace fragments of tumor DNA (cell-free DNA).

Request For Custom Research@ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=3637

Lack of Sensitivity and Specificity to Hamper Market

·         The success of any test to be used for screening, diagnostics or monitoring of a cancer is dependent on the specificity and sensitivity demonstrated by the test. The cancer diagnostics have to be specific to screen patients without cancer and sensitive enough to detect presence of even smallest tumor in the body. Presently, more than 1 million prostate biopsies are carried out in the U.S. and most of them are unnecessary or repeat biopsies only to ensure that a patient with cancer is not missed. It is a result of PSA test, not so specific test, being used for screening for prostate cancer. PSA test is being recommended for annual cancer screening by the American Cancer Society and the American Urologic Association. However, on the other hand, the National Cancer Institute, the American College of Physicians, and the U.S. Preventive Services Tasks Force do not recommend PSA test due of lack of evidence about specificity and its usefulness in reducing morbidity or mortality. Similarly, there is need for specific and sensitive biomarkers for detection of each cancer types that can be used for screening on wider population.

·          Therefore, the growth of cancer diagnostics market is expected to be negatively affected unless specific and highly sensitive diagnostic tests are introduced in the market.

Request Report Methodology@ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=3637

Global Cancer Diagnostics Market: Competitive Landscape

·         This report profiles major players in the global cancer diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

·         The global cancer diagnostics market is highly fragmented, with the presence of a number of international as well as regional players

·         Leading players operating in the global cancer diagnostics market are

o    Abbott

o    Ambry Genetics

o    AstraZeneca plc

o    bioMeriux SA

o    Eli Lilly and Company

o    Genoptix, Inc.

o    GlaxoSmithKline plc

o    F. Hoffmann-La Roche Ltd

o    Pfizer, Inc. 

o    among others

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

 For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

 Contact

 Rohit Bhisey

Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog: https://tmrblog.com Email: sales@transparencymarketresearch.com

[healthcaremresearch]

Histology Equipment Market Analysis, Business Development, Size, Share, Trends, Future Growth, Forecast to 2030

Histology Equipment market is projected to exhibit a CAGR of around 4.7% during the forecast period of 2022 to 2030.

The Histology Equipment Market Research Report seeks to give a brief outline of the industry's overall performance and noteworthy emerging trends. Here, significant findings, the most recent main drivers, and restrictions are also shown. Market analysts use a wide range of quantitative and qualitative methods, including as in-depth interviews, ethnography, customer surveys, and secondary data analysis. Major firms find it simple to gather crucial information about crucial organisations as well as insights into customer behaviour, market size, rivalry, and market need. Key companies may take informed decisions with ease by referring to this market study report on histology equipment.

The Histology Equipment Market Size is anticipated to increase between 2022 and 2028 as a result of growing consumer awareness of various skin diseases around the world. The presence of established and cutting-edge healthcare infrastructure is expected to fuel significant growth in the market for histology equipment. Other factors influencing market expansion include rising patient awareness and rising healthcare costs. Tissue samples are examined using histology equipment. Typically used to identify malignant or other diseased cells, which can be brought on by viruses, bacteria, or other pathogens, these tools remove and prepare samples for analysis. The devices investigate samples using a range of tools, such as spectrometers, cell counters, and microscopes.

Top Key Players:

Agilent

BioGenex

Biocare

Roche

Intelsint

Thermo Fisher

Leica

Sakura Finetek

By Types:

Tissue-processing Systems

Scanners

Slide-staining Systems

By Applications:

Research Laboratories

Pharmaceutical Companies

Hospitals

Request a sample copy of the report:@ https://healthcaremarketreports.com/sample-request/histology-equipment-market/68918/?utm_source=Niraj&utm_medium=Free

By Regions:

North America

Europe

China

Japan

Middle East and Africa

South America

India

South Korea

Southeast Asia

Others

Some Points from Table of Content:

1 Market Overview

2 Manufacturers Profiles

3 Blood Glucose Analysis Systems Sales by Manufacturer

4 Market Analysis by Region

5 Market Segment by Type

6 Market Segment by Application

7 North America by Country, by Type, and by Application

8 Europe by Country, by Type, and by Application

9 Asia-Pacific by Country, by Type, and by Application

10 South America by Country, by Type, and by Application

11 Middle East & Africa by Country, by Type, and by Application

12 Sales Channel, Distributors, Traders and Dealers

13 Research Findings and Conclusion

14 Appendix

Purchase this report:@ https://healthcaremarketreports.com/purchase/histology-equipment-market/68918/?license=single&utm_source=Niraj&utm_medium=Free

FAQs:

What is the driving factor for the growth of the Histology Equipment market?

How will the COVID-19 pandemic impact the demand and consumption of the Histology Equipment market?

What is the major application area of the Histology Equipment market?

Who are the Histology Equipment manufacturers across the globe?

Which geographical location is dominant in the Histology Equipment market?

Which are the top industry players in the Histology Equipment market?

About Us:

he healthcare industry is surely facing disruptions with global economies giving high importance to individual health. In this scenario, we expect our clients to get deep insights to power their innovations in the right direction. We have been keeping a close watch on the changes and modifications happening in the healthcare domain. As per our understanding, these alterations are active and unexampled.

Contact Us:

Healthcare Market Reports

sales@healthcaremarketreports.com  

+1(929)-450-2887

[healthcare-domain]

Higher Staining Technologies For Slide Stainer Market

The growth of this market include the increasing incidence of chronic diseases, increasing automation in laboratories, rising geriatric population, and increasing healthcare expenditure.

The report analyzes the global slide stainers market by product, technology, end user, and region. On the basis of product, the reagents segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the rising prevalence of chronic and infectious diseases, increasing healthcare expenditure, increasing public awareness, and growing demand for automation in diagnostics and clinical research.

Based on technology, the hematoxylin & eosin (H&E) segment accounted for the largest share of the global slide stainers market in 2017. The large share of this segment can be attributed to the fact that H&E staining is the initial staining technique for various diseases and is associated with better quality, ease of use, and higher throughput than most other staining technologies.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134046412

Based on end user, the hospitals and diagnostic centers segment is expected to register the highest CAGR during the forecast period. The growing prevalence of diseases and huge patient inflow in hospitals and diagnostic centers are some of the factors that are likely to boost the growth of this market during the forecast period.

The implementation of excise duty by the US government is expected to limit the market growth during the forecast period. In addition, dearth of skilled technicians and product recalls are some of the factors expected to restrain market growth during the forecast period.

Geographically, the global slide stainers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2017, North America accounted for the largest share of the slide stainers market, followed by Europe and Asia Pacific.

The prominent players in the global slide stainers market are Roche (Switzerland), Agilent (US), Danaher (US), BioGenex (US), Thermo Fisher Scientific (US), Sakura (Japan), Biocare Medical (US), Merck Group (Germany), General Data Company (US), and Hardy Diagnostics (US).

[herbalmedicine12]

Anatomic Pathology Market Latest Industry Trends, Trades, Supply, Demand, Prospects by 2028

Anatomic pathology is devoted to studying diseases and disease progression based on the macroscopic, microscopic, biochemical, immunologic, and molecular examination of organs and tissues. It entails evaluations of tissue specimens, including cervical scrapings (i.e., PAP smears); biopsies; surgical resections; and whole-body evaluations after autopsy. Factors such as increase in the prevalence of cancer and other diseases, and growing focus on personalized medicines are boosting the anatomic pathology market growth. However, the lack of skilled professionals and stringency of government regulations hamper the market growth.

Anatomic pathology is useful in identifying abnormalities that can help diagnose diseases, such as diabetes, kidney, and liver diseases, and manage treatments. It is frequently used to diagnose and treat various types of cancers. Histopathology, which involves studying tissue changes caused by diseases, is a vital part of anatomic pathology. Cancer has a major impact on society across the world. The burden of cancer on healthcare systems is significantly increasing worldwide as it is among the leading causes of death. According to the National Cancer Institute, in 2018, there were 18.1 million new cases and 9.5 million people died from the disease worldwide. The number of new cancer cases per year is expected to rise to 29.5 million, while the number of cancer-related death is likely to hike up to 16.4 million by 2040. ~30% of all premature deaths from non- communicable diseases among adults aged 30–69 are caused because of cancer. Lung cancer is the most frequently diagnosed cancer in the world.

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis – https://www.theinsightpartners.com/sample/TIPRE00002999/

Leading In-Vitro Diagnostics Market Players:

F.     Hoffmann-La Roche AG

Danaher

Hologic,     Inc,

Agilent     Technologies Inc

BioGenex

Diapath     S.p.A

Bio SB

Merck KGaA,

BD

PHC Holdings ��   Corporation

Segmentation:

Based on product and service, the anatomic pathology market is segmented into instruments, consumables, and services. The services segment is expected to hold the largest share of the market In 2021, and it is further expected to register the highest CAGR during the forecast period. Services offered by any anatomical pathology laboratories include anatomical records, necropsy/deceased care center, cytopathology, electron microscopy, histopathology, immunopathology, and surgical pathology. Cytopathology service facilities offer service, training, and scientific work assistance. The laboratory service area handles the preparation, staining, and microscopic examination of patient samples. Histopathology processes include routine surgical tissue processing, embedding, microtomy, and cytochemical staining while preparing the sample for review by pathologists. The majority of cancers are diagnosed with the help of histopathology operations.

Immunopathology-based diagnostic tests include autoimmune disease serologies, flow cytometry, immunohistochemistry, immunofluorescence microscopy, immunofixation, and high-resolution agarose electrophoresis. Surgical pathology labs receive all biopsy and surgical resection samples collected from patients, and the preliminary diagnosis involves examination of samples, followed by maintaining the laboratory information system. Anatomical pathology records help inform, transcribe, distribute, and archive final surgical pathology and autopsy reports. A surge in the prevalence of chronic diseases and increasing government support to develop advanced healthcare environments have created numerous potential opportunities for anatomical pathology service providers.

Our reports will help clients solve the following issues: –

Insecurity about the future:

Our research and insights help our clients anticipate upcoming revenue compartments and growth ranges. This will help our clients invest or divest their assets.

Understanding market opinions:

It is extremely vital to have an impartial understanding of market opinions for a strategy. Our insights provide a keen view on the market sentiment. We keep this reconnaissance by engaging with Key Opinion Leaders of a value chain of each industry we track.

Understanding the most reliable investment centers:

Our research ranks investment centers of market by considering their future demands, returns, and profit margins. Our clients can focus on most prominent investment centers by procuring our market research.

Evaluating potential business partners:

Our research and insights help our clients identify compatible business partners.

Immediate delivery of our off-the-shelf reports and pre booking of upcoming studies, through flexible and convenient payment methods – https://www.theinsightpartners.com/buy/TIPRE00002999/

In-Vitro Diagnostics Market Segmented by Region/Country: North America, Europe, Asia Pacific, Middle East & Africa, and Central & South America

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

[smitamaxi]

Global Cancer Diagnostics Market Size, Share Leaders, Opportunities Assessment, Development Status, Top Manufacturers, And Forecast 2021-2027

Global Cancer Diagnostics Market is anticipated to reach US$ 37.30 Bn. by 2027 from US$ 17.30 Bn. in 2020 at a CAGR of 11.6 % during a forecast period.

Cancer Diagnostics Market Overview:

Global Cancer Diagnostics Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2027, published by Maximize Market Research, is the culmination of thorough primary and secondary research. The study completely examines analysed insights in light of the market, as well as its ever-changing trends, industry environment, and all of the market's leading elements. This research approach was used to investigate the global Cancer Diagnostics market, and the results were logically presented in this report.

Market Scope:

Cancer Diagnostics The paper provides in-depth knowledge and comprehension of trends, dynamics, and other topics. The research identifies the most important changes that will have an impact on the sector. It can help you identify the data in the study, as well as examine the competitive landscape of key firms, market dynamics, and other factors that can help you establish whether your present marketing plans are on track and how to enhance them.

The qualitative and quantitative data in the Cancer Diagnostics Market research can help decision-makers figure out which market segments, regions, and driving variables are most likely to grow at a faster pace, as well as important potential areas.

Request for free sample: https://www.maximizemarketresearch.com/request-sample/21307

Segmentation:

The 5.7 percent CAGR in the global Imaging category is predicted to be driven by the United States, Canada, Japan, China, and Europe. These regional markets, which had a total market value of US$28.4 billion in 2020, are predicted to expand by around US$41.7 billion by the conclusion of the analysis period. China is one of the fastest-growing regional marketplaces in this group. By 2027, the Asia-Pacific market is predicted to reach $30.1 billion, led by countries like Australia, India, and South Korea, while Latin America is expected to rise at a 7.4 percent CAGR.

Get more Report Details : https://www.maximizemarketresearch.com/market-report/global-cancer-diagnostics-market/21307/

Key Players:

• Abbott Diagnostics • Agilent Technologies, Inc. • Becton • Dickinson and Company • bioMérieux • C.R. Bard, Inc. • F. Hoffmann-La Roche Ltd. • GE Healthcare (A Subsidiary of General Electric Company) • Hologic, Inc. • Illumina, Inc. • Philips Healthcare • Siemens Healthcare • Roche Diagnostics • QIAGEN N.V. • Thermo Fisher Scientific, Inc. • BD • NeoGenomics Laboratories, Inc. • Telerad Tech • GENERAL ELECTRIC COMPANY • Hologic Inc. • BioGenex • BioNTech Diagnostics GmbH • Koninklijke Philips N.V.

The competitive landscape is an important component that every crucial player should be aware of. The research illuminates the competitive landscape of the worldwide Cancer Diagnostics market, allowing readers to understand competitiveness at both the domestic and global levels. Areas of operation, production, and product portfolio are all important considerations. In addition, major parameters such as business size, market share, market growth, revenue, production volume, and profitability are examined in the report.

The study also focuses on BCG matrix, heat map analysis, Competitive Benchmarking, and SWOT analysis to better correlate market competitiveness.

Regional Analysis:

Geographically, this report is segmented into several key countries, with market size, growth rate, import and export of Cancer Diagnostics market in these countries, which covering North America, U.S., Canada, Mexico, Europe, UK, Germany, France, Spain, Italy, Rest of Europe, Asia Pacific, China, India, Japan, Australia, South Korea, ASEAN Countries, Rest of APAC, South America, Brazil, and Middle East and Africa.

COVID-19 Impact Analysis on Cancer Diagnostics Market:

According to the report, COVID-19 has a significant impact on the Cancer Diagnostics market in North America, Asia Pacific, the Middle East, Europe, and South America. During this crisis, the study examines a wide range of options, harsh conditions, and difficult scenarios in the Cancer Diagnostics market. In terms of funding and market expansion, the report briefly examines the COVID-19's merits as well as its limitations. In addition, the study presents a set of principles that readers may use to help them decide on and create a company strategy.

Key Questions answered in the Cancer Diagnostics Market Report are:

Which product segment grabbed the largest share in the Cancer Diagnostics market?

How is the competitive scenario of the Cancer Diagnostics market?

Which are the key factors aiding the Cancer Diagnostics market growth?

Which region holds the maximum share in the Cancer Diagnostics market?

What will be the CAGR of the Cancer Diagnostics market during the forecast period?

Which application segment emerged as the leading segment in the Cancer Diagnostics market?

Which are the prominent players in the Cancer Diagnostics market?

What key trends are likely to emerge in the Cancer Diagnostics market in the coming years?

What will be the Cancer Diagnostics market size by 2027?

Which company held the largest share in the Cancer Diagnostics market?

About Us:

Maximize Market Research provides B2B and B2C research on 12000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defence and other manufacturing sectors.

Contact Us:

MAXIMIZE MARKET RESEARCH PVT. LTD.

3rd Floor, Navale IT Park Phase 2,

Pune Bangalore Highway,

Narhe, Pune, Maharashtra 411041, India.

Email: sales@maximizemarketresearch.com

[researchupdates]

Tissue Processing Systems Market May See a Big Move by 2027 | Roche, Thermo Fisher, BioGenex

Overview of Global Tissue Processing Systems Market:

Tissue Processing Systems Market research report has been created with the systematic gathering and evaluation of market information for Healthcare industry which is presented in a form that explains various facts and figures to the business. This market survey document contains thorough analysis of market and numerous related factors that range from market drivers, market restraints, market segmentation, opportunities, challenges, and market revenues to competitive analysis. It lends a hand to companies in taking decisive actions to deal with threats in niche market. A brilliant team of analysts, experts, statisticians, forecasters and economists has worked rigorously to generate advanced and all-inclusive Tissue Processing Systems market report.

The Global Tissue Processing Systems Market is expected to USD 475.54 Million by 2027 growing at a CAGR of 5.78% in the forecast period of 2020 to 2027.

Available Exclusive Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-tissue-processing-systems-market&paragp .

Some of the most significant key factors driving the growth of the Global Tissue Processing Systems Market are increasing healthcare expenditure, growing cases of cancer worldwide, rising ageing population, increasing cases of lifestyle diseases, advancement in the technology and increasing government initiatives to offer affordable advanced healthcare solutions.

Top Leading Key Manufacturers are: Leica Biosystems Nussloch, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, BioGenex, JOKOH, Bio Optica Milano Spa, MEDITE Medical GmbH, Agar Scientific Ltd., MILESTONE MEDICALSLEE medical GmbH, Sakura Finetek USA, Inc., Siemens Healthcare Private Limited and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

In terms of the geographic analysis, APAC dominates the Tissue Processing Systems Market in the forecast period of 2020 to 2027 due to improvement in the healthcare infrastructure and rising ageing population in the region is expected to enhance the market growth in the region.

Access Complete Report Here: https://www.databridgemarketresearch.com/reports/global-tissue-processing-systems-market?utm_source=parag&utm_medium=pingale&utm_campaign=parag&utm_id=parag .  

[rdagade]

Global Cancer Diagnostics Market: Scope, Share, Future, Opportunity, Driver, Status, Forecast to 2027

Cancer Diagnostics Market Overview: Maximize Market Research has Published an intelligence report entitled Global Cancer Diagnostics Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2027 that is the complete creation of meticulous primary and secondary research. The report thoroughly covers analysed insights in view of the market along with its ever-changing patterns, industry environment, and all dominant aspects of the market. This research methodology has been applied to examine the global Cancer Diagnostics market and these findings have been logically mentioned in this report. Request For Free Sample: https://www.maximizemarketresearch.com/request-sample/21307

Market Scope: Global Cancer Diagnostics Market 2021 research report 2027 provides vital statistics and analytical knowledge to grant an entire understanding of the market size, share, growth, trend, demand, top player and industry summary, opportunities, worth cycle, end-users, technology, types and application. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The qualitative and quantitative data provided in the Cancer Diagnostics market study can help decision-makers understand which market segments, regions are expected to grow at higher rates, factors affecting the market, and key opportunity areas. The report also includes the competitive landscape of key players in the industry along with emerging trends in the Cancer Diagnostics market. PESTEL Analysis: The reports provided by Maximize Market Research provide PESTEL analysis to help you shape your business strategy. Political factors such as taxation, environmental regulations and tariffs help governments determine the extent to which they can influence the Cancer Diagnostics market. Economic factors such as interest rates, exchange rates, inflation and wage rates, and minimum wages can help you analyze the determinants of economic performance that affect the Cancer Diagnostics market. Legal factors help us understand the impact of environmental impacts and consideration on the market. Segmentation:

Cancer Diagnostics Market

Report CoverageDetails

Base Year:2020Forecast Period:2021-2027

Historical Data:2016 to 2020Market Size in 2020:US $ 17.30 Bn.

Forecast Period 2021 to 2027 CAGR:11.6  %Market Size in 2027:US $ 37.30 Bn.

Segments Covered:by Product• Laboratory Tests • Genetic Tests • Imaging • Endoscopy • Biopsy • Others

by Application• Breast Cancer • Colorectal Cancer • Cervical Cancer • Lung Cancer • Prostate Cancer • Skin Cancer • Blood Cancer • Kidney Cancer • Liver Cancer • Pancreatic Cancer • Ovarian Cancer • Others

Key Players: • Abbott Diagnostics • Agilent Technologies, Inc. • Becton • Dickinson and Company • bioMérieux • C.R. Bard, Inc. • F. Hoffmann-La Roche Ltd. • GE Healthcare (A Subsidiary of General Electric Company) • Hologic, Inc. • Illumina, Inc. • Philips Healthcare • Siemens Healthcare • Roche Diagnostics • QIAGEN N.V. • Thermo Fisher Scientific, Inc. • BD • NeoGenomics Laboratories, Inc. • Telerad Tech • GENERAL ELECTRIC COMPANY • Hologic Inc. • BioGenex • BioNTech Diagnostics GmbH • Koninklijke Philips N.V. The competitive landscape is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global Cancer Diagnostics market to know the competition at both the domestic and global levels. The key aspects such as areas of operation, production, and product portfolio. Additionally, companies in the report are studied based on key factors such as company size, market share, market growth, revenue, production volume, and profits. In additional Cancer Diagnostics Market Share analysis of players, in-depth profiling, product/service and business overview, the study also concentrates on BCG matrix, heat map analysis, Competitive Benchmarking along with SWOT analysis to better correlate market competitiveness. Get more Report Details: https://www.maximizemarketresearch.com/market-report/global-cancer-diagnostics-market/21307/

Regional Analysis: Geographically, this report is segmented into several key countries, with market size, growth rate, import and export of Cancer Diagnostics market in these countries, which covering North America, U.S., Canada, Mexico, Europe, UK, Germany, France, Spain, Italy, Rest of Europe, Asia Pacific, China, India, Japan, Australia, South Korea, ASEAN Countries, Rest of APAC, South America, Brazil, and Middle East and Africa. COVID-19 Impact Analysis on Cancer Diagnostics Market: The report has identified detailed impact of COVID-19 on Cancer Diagnostics market in regions such as North America, Asia Pacific, Middle-East, Europe, and South America. The report provides Comprehensive analysis on alternatives, difficult conditions, and difficult scenarios of Cancer Diagnostics market during this crisis. The report briefly elaborates the advantages as well as the difficulties in terms of finance and market growth attained during the COVID-19. In addition, report offers a set of concepts, which is expected to aid readers in deciding and planning a strategy for their business. Key Questions answered in the Cancer Diagnostics Market Report are: Which product segment grabbed the largest share in the Cancer Diagnostics market? How is the competitive scenario of the Cancer Diagnostics market? Which are the key factors aiding the Cancer Diagnostics market growth? Which region holds the maximum share in the Cancer Diagnostics market? What will be the CAGR of the Cancer Diagnostics market during the forecast period? Which application segment emerged as the leading segment in the Cancer Diagnostics market? Which are the prominent players in the Cancer Diagnostics market? What key trends are likely to emerge in the Cancer Diagnostics market in the coming years? What will be the Cancer Diagnostics market size by 2027? Which company held the largest share in the Cancer Diagnostics market? About Us: Maximize Market Research provides B2B and B2C research on 12000 high growth emerging opportunities technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics Communications, Internet of Things, Food and Beverages, Aerospace and Defence and other manufacturing sectors. Contact Us: MAXIMIZE MARKET RESEARCH PVT. LTD. 3rd Floor, Navale IT Park Phase 2, Pune Bangalore Highway, Narhe, Pune, Maharashtra 411041, India. Phone No.: +91 20 6630 3320

[healthcaremarketfmi]

Anatomic Pathology Market Opportunities, Threats, Drivers, Restraints, Trends, Applications, And Growth Forecast To 2030

The global anatomic pathology market forecast is set to reach US$ 61.1 Mn in revenues by 2030, according to a new market study by ESOMAR-certified market research firm, Future Market Insights (FMI).Anatomic Pathology Market Size (2022)US$ 32.5 MnAnatomic Pathology Market Revenue Forecast (2030)US$ 61.1 MnAnatomic Pathology Market Growth Rate (2022-2030)8.2% CAGRNorth America Market Share37.1%

The anatomic pathology market is subject to integrating medical informatics standards to meet specific healthcare requirements by curtailing costs and improvising on efficiency.

Pathology laboratories are on the verge of refurbishment as new-fangled disease diagnostic models are making a beeline therein.

As of now, lymphoma, breast cancer, colorectal cancer, prostate cancer, cervical cancer, and lung cancer are a part of anatomic pathology.

Key Takeaways

The instruments are subject to technological advancements, which would minimize errors. This factor is expected to drive the anatomic pathology market between 2022 and 2030

Consumables are expected to hold the largest market share due to low cost, high availability, and good purchase rate of probes and reagents

Academic research is bound to pick up pace in the forecast period owing to growing implementation of anatomic pathology in biomarker profiling and tumor examination

Preference to personalized therapies is prompting putative biomarkers being discovered. This factor is expected to be one of the key growth drivers

Key Participant Insights

The key market players are focusing on technological upgradations and expansion strategies to keep themselves fiercely competitive.

For instance –

In Jul 2020, Bio SB tabled its Fast Mohs PolyDetector Plus Detection System, which comes across as a super sensitive nonbiotin monovalent Fab micropolymer immunohistochemistry system to detect IVD antibodies for squamous cell carcinoma, basal cell carcinoma, and melanoma.

In Jan 2019, Quest Diagnostics announced completion of acquisition of the US laboratory services business that belonged to Oxford Immunotec (the T-Spot and Accutix tick-borne disease testing services, since then, are part of Quest’s infectious disease testing services.

In 2018, Leica Microsystems entered into a collaboration with Thermo Fisher to develop an integrated cryotomography workflow with regards to research.

For More information : https://www.futuremarketinsights.com/reports/anatomic-pathology-market

The other players in the veterinary imaging market include

Laboratory Corporation of America Holdings

Sakura Finetek USA, Inc.

F.Hoffmann-La Roche AG

Cardinal Health, Inc.

BioGenex

NeoGenomics

Agilent Technologies

The US continues to be one of the leading markets for anatomic pathology market globally. Strong presence of some of the leading players, combined with relatively easier funding for R&D will drive the US anatomic pathology market during the assessment period.

The Europe anatomic pathology market is also likely to grow at a brisk pace during the assessment period. The growth will remain concentrated in Western Europe, as has been the case traditionally.

Asia Pacific represents a high growth market for anatomic pathology stakeholders. Many countries in the region are renewing their focus on healthcare, as the current Covid-19 crisis has reinforced the necessity of a robust healthcare system.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global anatomic pathology market is segmented in detail to cover every aspect and present a complete market intelligence approach to the reader.

The study provides compelling insights on anatomic pathology market on the basis of product & services type (Instruments (Microtomes & Cryostat, Tissue processors, Automatic Stainers, and Other products), consumables (Reagents & Antibodies, Probes & Kits, and Others), application (Disease Diagnosis, Drug Discovery and Development, and Others), and services (histopathology, cytopathology)) across seven geographies.

Inquire Before Buying This Research Report: https://www.futuremarketinsights.com/ask-question/rep-gb-12370

Key Segments of Anatomic Pathology Industry Survey

Anatomic Pathology Market by Product & Service:

Anatomic Pathology Instruments

Anatomic Pathology Consumables

Anatomic Pathology Services

Anatomic Pathology Market by Application:

Disease Diagnosis

Drug Discovery and Development

Others

Anatomic Pathology Market by End User:

Hospitals

Research Laboratories

Diagnostic Laboratories

Others

[marketerefforts]

In Situ Hybridization Market Research Report 2023 - Industry Size, Share, Demands, Regional Analysis & Estimations Till 2028

The In Situ Hybridization Market Report, in its latest update, highlights the significant impacts and the recent strategical changes under the present socio-economic scenario. The In Situ Hybridization industry growth avenues are deeply supported by exhaustive research by the top analysts of the industry. The report starts with the executive summary, followed by a value chain and marketing channels study. The report then estimates the CAGR and market revenue of the Global and regional segments.

Base Year: 2021

Estimated Year: 2022

Forecast Till: 2023 to 2028

The report classifies the market into different segments based on type and product. These segments are studied in detail, incorporating the market estimates and forecasts at regional and country levels. The segment analysis is helpful in understanding the growth areas and potential opportunities of the market.

Get | Download FREE Sample Report of Global In Situ Hybridization Market @ https://www.decisiondatabases.com/contact/download-sample-18103

A special section is dedicated to the analysis of the impact of the COVID-19 pandemic on the growth of the In Situ Hybridization market.  The impact is closely studied in terms of production, import, export, and supply.

The report covers the complete competitive landscape of the Worldwide In Situ Hybridization market with company profiles of key players such as:

Abbott Laboratories

Advanced Cell Diagnostics, Inc.

Agilent Technologies, Inc. 

Biogenex Laboratories, Inc.

Danaher Corporation

F.Hoffmann-La Roche Ltd.

Merck KGaA

Perkin Elmer, Inc.

Thermofisher Scientific, Inc.

Want to add more Company Profiles to the Report? Write your Customized Requirements to us @ https://www.decisiondatabases.com/contact/get-custom-research-18103

In Situ Hybridization Market Analysis by Technique:

Fluorescence In Situ Hybridization (FISH)

DNA-FISH

RNA-FISH

Chromogenic In Situ Hybridization (CISH)

In Situ Hybridization Market Analysis by Application:

Cancer Diagnosis

Immunology

Neuroscience

Cytology

Infectious Diseases

In Situ Hybridization Market Analysis by End-User:

Molecular Diagnostic Laboratories

Pharmaceutical & Biotechnology Companies

Contract Research Organizations (CROS)

Academic & Research Institutions

In Situ Hybridization Market Analysis by Geography:

North America (USA, Canada, and Mexico)

Europe (Germany, UK, France, Italy, Russia, Spain, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Australia, South-East Asia, Rest of Asia-Pacific)

Latin America (Brazil, Argentina, Peru, Chile, Rest of Latin America)

The Middle East and Africa (Saudi Arabia, UAE, Israel, South Africa, Rest of the Middle East and Africa)

Key questions answered in the report:

 What is the expected growth of the In Situ Hybridization market between 2023 to 2028?

Which application and type segment holds the maximum share in the Global In Situ Hybridization market?

Which regional In Situ Hybridization market shows the highest growth CAGR between 2023 to 2028?

What are the opportunities and challenges currently faced by the In Situ Hybridization market?

Who are the leading market players and what are their Strengths, Weakness, Opportunities, and Threats (SWOT)?

What business strategies are the competitors considering to stay in the In Situ Hybridization market?

Purchase the Complete Global In Situ Hybridization Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-18103

About Us:

DecisionDatabases.com is a global business research report provider, enriching decision-makers, and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research reports, customized research reports, company profiles, and industry databases across multiple domains. Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise, and meaningful data at a lightning speed.

For more details: DecisionDatabases.com E-Mail: sales@decisiondatabases.com Phone: +91 90 28 057900 Web: https://www.decisiondatabases.com/

[pranalipawarshinde]

Cancer Diagnostics Market Emerging Factors, Future Demands and Report 2027

Cancer Diagnostics Market: Overview

 According to Transparency Market Research’s latest report on the global Cancer diagnostics Market for the historical period 2017–2018 and forecast period 2019–2027, Increasing trend for preventive diagnosis due to escalating prevalence continues, early diagnosis enables better clinical and economical outcomes for patients are projected to drive the global cancer diagnostics market during the forecast period

According to the report, the global cancer diagnostics market was valued at US$ 146.2 Bn in 2018 and is anticipated to expand at a CAGR of 8.8% from 2019 to 2027

Increasing trend for preventive diagnosis due to escalating prevalence continues and early diagnosis enables better clinical and economical outcomes for patients: Key Drivers

·         Cancer has a major impact on society across the world. It is one of the leading causes of death across the globe and is more prevalent in developed and emerging markets. According to American Cancer Society data, over 1.7 million new cancer cases are expected to be diagnosed in 2019 in the U.S. According to information published in the European Journal of Cancer, an estimated 3.9 million new cases of cancer and 1.9 million deaths due to the disease were reported in Europe in 2018.

·         The alarming rate of escalating cancer prevalence compels the healthcare providers to rethink of goals of treating cancer and also focus on prevention. This would require cancer diagnostics that are not only specific and sensitive, but also capable of detecting cancer in early stages. As the prevalence of different types of cancer grows globally, it is expected to drive the global cancer diagnostics market.

·         The high cost of treatment for any kind of cancer is a key driver for increasing market for diagnostic tests and procedures. Cancer is a chronic disease and usually incurs expensive treatment along with debilitating pain, disability and in some cases death. An early detection by use of most modern diagnostics enables quick medical decision making and consequent treatment. This ensures that the cancer does not prevail until it becomes very difficult to treat. Therefore, cancer diagnostics have significant role in reduction of treatment costs, lowering of hospitalization stay, and prevention of unavoidable interventions. Early diagnosis does not necessarily mean cost saving in the treatment of disease. It allows early treatment which results into improved quality of life and ‘quality adjusted life years’ (QALY) gained. The life years gained suffices the justification of even costlier cancer diagnostics and thus provides even better outlook for the Cancer Diagnostics Market

Request A Sample@

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3637

Novel Diagnostic Biomarkers Continue To Create New Revenue Stream Boost Market Growth

 ·         The increased knowledge about specific cancer biomarkers is providing great market opportunity to treat cancer patients through improvement in the detection. The technological advancements in the field of biotechnology have enabled the identification of potential cancer biomarkers and some of these biomarkers have been commercialized.

·         In February 2020, Biocare Medical launched of seven novel IVD immunohistochemistry antibody markers for clinical diagnostics and research applications.

·         In May 2020, BioGenex introduced three new primary immunohistochemistry (IHC) antibodies for cancer diagnosis. The new launch includes: CD8A, CD56, CD163

·         In 2014, Guardant Health introduced GUARDANT360 blood test that sequences patient’s cancer in real-time through genetic profiling of trace fragments of tumor DNA (cell-free DNA).

Request For Custom Research@ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=3637

Lack of Sensitivity and Specificity to Hamper Market

·         The success of any test to be used for screening, diagnostics or monitoring of a cancer is dependent on the specificity and sensitivity demonstrated by the test. The cancer diagnostics have to be specific to screen patients without cancer and sensitive enough to detect presence of even smallest tumor in the body. Presently, more than 1 million prostate biopsies are carried out in the U.S. and most of them are unnecessary or repeat biopsies only to ensure that a patient with cancer is not missed. It is a result of PSA test, not so specific test, being used for screening for prostate cancer. PSA test is being recommended for annual cancer screening by the American Cancer Society and the American Urologic Association. However, on the other hand, the National Cancer Institute, the American College of Physicians, and the U.S. Preventive Services Tasks Force do not recommend PSA test due of lack of evidence about specificity and its usefulness in reducing morbidity or mortality. Similarly, there is need for specific and sensitive biomarkers for detection of each cancer types that can be used for screening on wider population.

·          Therefore, the growth of cancer diagnostics market is expected to be negatively affected unless specific and highly sensitive diagnostic tests are introduced in the market.

Request Report Methodology@ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=3637

Global Cancer Diagnostics Market: Competitive Landscape

·         This report profiles major players in the global cancer diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

·         The global cancer diagnostics market is highly fragmented, with the presence of a number of international as well as regional players

·         Leading players operating in the global cancer diagnostics market are

o    Abbott

o    Ambry Genetics

o    AstraZeneca plc

o    bioMeriux SA

o    Eli Lilly and Company

o    Genoptix, Inc.

o    GlaxoSmithKline plc

o    F. Hoffmann-La Roche Ltd

o    Pfizer, Inc. 

o    among others

More Trending Reports by Transparency Market Research:

 Cervical Cancer Diagnostic Tests Market: https://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html

Central Lab Market: https://www.transparencymarketresearch.com/central-lab-market.html

In Vitro Diagnostics Market: https://www.transparencymarketresearch.com/in-vitro-diagnostic-tests.html

ASRs and RUOs Market: https://www.transparencymarketresearch.com/us-asrs-and-ruos-market.html

Companion Diagnostics Market: https://www.transparencymarketresearch.com/companion-diagnostics-market.html

Europe and Middle East & Africa Respiratory Panel Testing Market: https://www.transparencymarketresearch.com/emea-respiratory-panel-testing-market.html

Direct-to-Consumer Laboratory Testing Market: https://www.transparencymarketresearch.com/north-america-direct-to-consumer-laboratory-testing-market.html

Pressure Ulcer Diagnostics Market: https://www.transparencymarketresearch.com/pressure-ulcer-diagnostics-market.html

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

 Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

 For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

 Contact

 Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog: https://tmrblog.com Email: sales@transparencymarketresearch.com

[itssashasharma]

Global Anatomic Pathology Market worth $ 49.1 billion by 2026 : High incidence of cancer and other target diseases

The study involved four major activities in estimating the current size of the anatomic pathology market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

According to the new market research report “Anatomic Pathology Market by Product & Service [Instruments (Tissue Processors, Microtome), Consumables (Antibodies), Histopathology], Application (Disease Diagnosis (Cancer (Gastrointestinal, Lung)], End User, Region – Global Forecasts to 2025″, published by MarketsandMarkets™, the Anatomic Pathology Market is projected to reach a value of USD 46.8 billion by 2025 from USD 33.3 billion in 2020, at a CAGR of 7.1% from 2020 to 2025.

The growth in this market is majorly driven by the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to a certain extent during the forecast period.

Browse in-depth TOC on “Anatomic Pathology Market“

457 – Tables

34 – Figures

306 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

The high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine are the major factors driving the growth of the anatomic pathology

The services segment accounted for the largest share of the market, by product & service, in 2019

Based on product & service, the Anatomic Pathology Market is segmented into services, consumables, and instruments. The services segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the availability of reimbursements for diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.

Hospital laboratories segment to register the highest growth rate during the forecast period

Based on end-users, the market is segmented into hospital laboratories, clinical laboratories, and other end users. In 2019, the hospital laboratories segment accounted for the largest market share and is expected to grow at the highest CAGR during the forecast period. The growth in this market can be attributed to the increasing number of patient visits to hospitals, a growing number of in-house diagnostic procedures performed in hospitals, rising awareness regarding early disease diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.

North America is the largest regional market for anatomic pathology

By region, the Anatomic Pathology Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest market share, followed by Europe. The rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the market in North America.

The prominent players operating in the Anatomic Pathology Market include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (Italy), and BioGenex Laboratories (US).

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Anatomic Pathology Track and Trace Solutions Market

by Product (Software, Hardware (Printer & Labeling Systems), Consumables), Technology (Barcode, RFID), Application (Tissue Cassette, Slide Tracking), End User (Hospital Labs) – Global Forecast to 2023

https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology-track-trace-solution-market-124099392.html

Slide Stainer Market by Product (Reagent, Equipment (Automated, Manual)), Technology (Hematoxylin & Eosin, Immunohistochemistry, In Situ Hybridization, Microbiology, Special Stains), End User (Hospital, Pharmaceutical, Academic) – Global Forecast to 2023

https://www.marketsandmarkets.com/Market-Reports/slide-stainer-market-134046412.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/anatomic-pathology-market.asp

Visit Our Website: https://www.marketsandmarkets.com

Content Source: https://www.marketsandmarkets.com/PressReleases/anatomic-pathology.asp